Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Raben

Showing results (21-30 of 161) with videos related to

Pageof 17
Sort By:
Cancer|November 28, 2007
Poor prognosis in patients with stage I and II oral tongue squamous cell carcinomaKyle Rusthoven, Ari Ballonoff, David Raben, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Understanding the mechanisms of action of EGFR inhibitors in NSCLC: what we know and what we do not knowDavid Raben, Barb Helfrich, Fortunato Ciardiello, et al.
Seminars in Radiation Oncology|April 20, 2004
Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?David Raben, Cataldo Bianco, Luka Milas, et al.
Medical Physics|March 17, 2010
Impact of anatomical interventions on the localization of post-prostatectomy cancer patientsQuentin Diot, Christine Olsen, Brian Kavanagh, et al.
Lancet (London, England)|May 20, 2008
Head and neck cancerAthanassios Argiris, Michalis V Karamouzis, David Raben, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2010
Dosimetric effect of online image-guided anatomical interventions for postprostatectomy cancer patientsQuentin Diot, Christine Olsen, Brian Kavanagh, et al.
Cancer Chemotherapy and Pharmacology|March 30, 2007
Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenograftsDaniel L Gustafson, Barbara Frederick, Andrea L Merz, et al.
Head & Neck|March 9, 2011
Microcystic adnexal carcinoma of the face treated with radiation therapy: a case report and review of the literatureThomas J Pugh, Nancy Y Lee, Theresa Pacheco, et al.
Practical Radiation Oncology|July 5, 2017
Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysisWilliam A Stokes, Brian D Kavanagh, David Raben, et al.
Clinical Lung Cancer|May 27, 2008
High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trialsKyle E Rusthoven, Thomas W Flaig, David Raben, et al.
Pageof 17

Showing results (21-30 of 161) with videos related to

Sort By:
Pageof 17
Cancer|November 28, 2007
Poor prognosis in patients with stage I and II oral tongue squamous cell carcinomaKyle Rusthoven, Ari Ballonoff, David Raben, et al.
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Understanding the mechanisms of action of EGFR inhibitors in NSCLC: what we know and what we do not knowDavid Raben, Barb Helfrich, Fortunato Ciardiello, et al.
Seminars in Radiation Oncology|April 20, 2004
Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?David Raben, Cataldo Bianco, Luka Milas, et al.
Medical Physics|March 17, 2010
Impact of anatomical interventions on the localization of post-prostatectomy cancer patientsQuentin Diot, Christine Olsen, Brian Kavanagh, et al.
Lancet (London, England)|May 20, 2008
Head and neck cancerAthanassios Argiris, Michalis V Karamouzis, David Raben, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2010
Dosimetric effect of online image-guided anatomical interventions for postprostatectomy cancer patientsQuentin Diot, Christine Olsen, Brian Kavanagh, et al.
Cancer Chemotherapy and Pharmacology|March 30, 2007
Dose scheduling of the dual VEGFR and EGFR tyrosine kinase inhibitor vandetanib (ZD6474, Zactima) in combination with radiotherapy in EGFR-positive and EGFR-null human head and neck tumor xenograftsDaniel L Gustafson, Barbara Frederick, Andrea L Merz, et al.
Head & Neck|March 9, 2011
Microcystic adnexal carcinoma of the face treated with radiation therapy: a case report and review of the literatureThomas J Pugh, Nancy Y Lee, Theresa Pacheco, et al.
Practical Radiation Oncology|July 5, 2017
Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysisWilliam A Stokes, Brian D Kavanagh, David Raben, et al.
Clinical Lung Cancer|May 27, 2008
High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trialsKyle E Rusthoven, Thomas W Flaig, David Raben, et al.
Pageof 17